FUM — Futura Medical Share News
0.000.00%
Last trade - 00:00- £2.92m
- -£0.48m
- £1.70m
AGM Statement
Notice of AGM and availability of Annual Report
Brief: Futura Medical Expects 2024 To Be Year Of Precise Execution With Further Commercialisation Of Eroxon
Results for the Year ended 31 December 2023
Notice of Results and Investor Presentation
Eroxon to be available on prescription
UK's Futura Medical soars after strong 2023 performance
Brief: Futura Medical Sees FY Revenues From Product Sales Of 3.1 Mln Stg
Trading Update
Director/PDMR Dealing
Brief: Futura Medical Extends Exclusive Licensing Agreement With Cooper
Appointment of Roy Davis as Non-Executive Director
Brief: Futura Medical Expands Partnership With M8 Pharmaceuticals
Futura expands partnership with M8 Pharmaceuticals
Eroxon Awarded “New Product of the Year” by Boots
Eroxon® Granted Marketing Authorisation in Mexico
Brief: Futura Medical PLC says Eroxon Launches In United Arab Emirates
Eroxon Launches in the United Arab Emirates
Directors’/PDMR Dealing and Grant of Options